Nutrition intervention: a strategy against systemic inflammatory syndrome

Area of Science:

• Nutritional Science
• Gastroenterology
• Critical Care Medicine

Background:

• Sepsis and septic shock are leading causes of mortality in critically ill patients.
• Bacterial lipopolysaccharide (LPS) translocation can trigger systemic inflammation and organ damage.
• Investigating targeted nutritional interventions is crucial for managing sepsis.

Purpose of the Study:

• To evaluate the efficacy of an enteral formula enriched with cysteine, omega-3 fatty acids (EPA/DHA), and fructooligosaccharides (FOS) in mitigating LPS-induced systemic inflammatory responses.
• To compare the protective effects of this specialized formula against standard and control diets in a rat model of sepsis.

Main Methods:

• Rats were fed one of three diets: a standard soy-based diet (CHOW), a specialized whey-peptide-based diet (CYSPUFA), or a casein-based control diet (CASN).
• After six days, rats received an intraperitoneal injection of lipopolysaccharide (LPS) to induce a sepsis-like state.
• Body weight changes, inflammatory cytokine levels, liver enzyme release (alanine aminotransferase), and hepatic pathology were assessed.

Main Results:

• Rats receiving the CYSPUFA diet exhibited significantly less weight loss post-LPS administration compared to CHOW and CASN groups.
• The CYSPUFA group demonstrated improved liver enzyme concentrations and reduced hepatic pathology following LPS challenge.
• While inflammatory cytokines increased in all LPS-treated groups, the CYSPUFA diet appeared to mitigate the severity of organ damage.

Conclusions:

• The enteral formula (CYSPUFA), rich in EPA/DHA, FOS, and cysteine, provides significant protection against LPS-induced systemic inflammation and organ injury.
• These findings suggest that this specialized nutritional approach warrants further investigation in clinical trials for critically ill patients with sepsis.